1-4 of 4
Haruhiko Fukuda
Close
Sort by
Journal Articles

The Response Evaluation Criteria in Solid Tumors Can be Substituted for the International Workshop Criteria?: Comparison Using Japan Clinical Oncology Group Study JCOG0203 for Untreated Indolent B-Cell Lymphoma

Kenichi Miyamoto, MD, Takashi Watanabe, MD PhD, Hideaki Kitahara, MD, Masashi Wakabayashi, MSc, Kenichi Nakamura, MD, Yuko Watanabe, Dai Maruyama, MD PhD, Kensei Tobinai, MD, PhD, Kunihiro Tsukasaki, MD, Haruhiko Fukuda, MD
Journal: Blood
Blood (2016) 128 (22): 4779.
https://doi.org/10.1182/blood.V128.22.4779.4779
Published: 2016
Journal Articles

Characterization of Long-Term Survivors and a Predictive Model for Aggressive Adult T-Cell Leukemia-Lymphoma (ATL): An Ancillary Study by the Japan Clinical Oncology Group, JCOG0902A

Takuya Fukushima, MD, PhD, Shogo Nomura, Masanori Shimoyama, MD, PhD, Atae Utsunomiya, MD, PhD, Taro Shibata, MSc, Kenji Ishitsuka, MD, PhD, Yukiyoshi Moriuchi, MD, Shinichiro Yoshida, MD, PhD, Naokuni Uike, MD, PhD, Hiroyuki Hata, MD, PhD, Fumio Kawano, MD, PhD, Eisaburo Sueoka, MD, PhD, Kimiharu Uozumi, MD, PhD, Masato Masuda, MD, PhD, Yasuaki Yamada, MD, PhD, Harumi Kaba, Yuko Watanabe, Haruhiko Fukuda, MD, Tomomitsu Hotta, MD, PhD, Kensei Tobinai, MD, PhD, Kunihiro Tsukasaki, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 881.
https://doi.org/10.1182/blood.V118.21.881.881
Published: 2011
Journal Articles

Phase II Study of Chemotherapy (Cx) and Stem Cell Transplantation (SCT) for Adult Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LBL): Long-Term Follow-up Results of Japan Clinical Oncology Group (JCOG) Study 9402.

Teruhisa Azuma, MD, Kensei Tobinai, MD, PhD, Kunihiko Takeyama, MD, PhD, Taro Shibata, MSc, Haruhiko Fukuda, MD, PhD, Fumio Kawano, MD, PhD, Keiko Aikawa, MD, PhD, Masaharu Kasai, MD, PhD, Takaaki Chou, MD, PhD, Masayuki Sano, MD, PhD, Kuniaki Itoh, MD, PhD, Toshiaki Sai, MD, PhD, Hisashi Yamada, MD, PhD, Kiyoshi Mukai, MD, PhD, Tomomitsu Hotta, MD, PhD, Masanori Shimoyama, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3087.
https://doi.org/10.1182/blood.V114.22.3087.3087
Published: 2009
Journal Articles

Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-Cell Leukemia-Lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.

Kunihiro Tsukasaki, MD, PhD, Takuya Fukushima, Atae Utsunomiya, Syuichi Ikeda, Masato Masuda, Kensei Tobinai, Haruhiko Fukuda, Masanori Shimoyama, Masao Tomonaga, Tomomitu Hotta, Members of the Lymphoma Study Group of JCOG
Journal: Blood
Blood (2005) 106 (11): 812.
https://doi.org/10.1182/blood.V106.11.812.812
Published: 2005